Subtype of atrial fibrillation and the outcome of transcatheter aortic valve replacement: The FinnValve Study

Visa fullständig post



Permalänk

http://hdl.handle.net/10138/319504

Citation

Jaakkola , J , Jaakkola , S , Airaksinen , K E J , Husso , A , Juvonen , T , Laine , M , Virtanen , M , Maaranen , P , Niemelä , M , Mäkikallio , T , Savontaus , M , Tauriainen , T , Valtola , A , Vento , A , Eskola , M , Raivio , P & Biancari , F 2020 , ' Subtype of atrial fibrillation and the outcome of transcatheter aortic valve replacement: The FinnValve Study ' , PLoS One , vol. 15 , no. 9 , 0238953 . https://doi.org/10.1371/journal.pone.0238953

Titel: Subtype of atrial fibrillation and the outcome of transcatheter aortic valve replacement: The FinnValve Study
Författare: Jaakkola, Jussi; Jaakkola, Samuli; Airaksinen, K. E. Juhani; Husso, Annastiina; Juvonen, Tatu; Laine, Mika; Virtanen, Marko; Maaranen, Pasi; Niemelä, Matti; Mäkikallio, Timo; Savontaus, Mikko; Tauriainen, Tuomas; Valtola, Antti; Vento, Antti; Eskola, Markku; Raivio, Peter; Biancari, Fausto
Upphovmannens organisation: HUS Heart and Lung Center
III kirurgian klinikka
Clinicum
Department of Surgery
Kardiologian yksikkö
Helsinki University Hospital Area
Datum: 2020-09-11
Språk: eng
Sidantal: 12
Tillhör serie: PLoS One
ISSN: 1932-6203
DOI: https://doi.org/10.1371/journal.pone.0238953
Permanenta länken (URI): http://hdl.handle.net/10138/319504
Abstrakt: Whether the subtype of atrial fibrillation affects outcomes after transcatheter aortic valve replacement for aortic stenosis is unclear. The nationwide FinnValve registry included 2130 patients who underwent primary after transcatheter aortic valve replacement for aortic stenosis during 2008–2017. Altogether, 281 (13.2%) patients had pre-existing paroxysmal atrial fibrillation, 651 (30.6%) had pre-existing non-paroxysmal atrial fibrillation and 160 (7.5%) were diagnosed with new-onset atrial fibrillation during the index hospitalization. The median follow-up was 2.4 (interquartile range: 1.6–3.8) years. Paroxysmal atrial fibrillation did not affect 30-day or overall mortality (p-values >0.05). Non-paroxysmal atrial fibrillation demonstrated an increased risk of overall mortality (hazard ratio: 1.61, 95% confidence interval: 1.35–1.92; p0.05). In conclusion, non-paroxysmal atrial fibrillation and new-onset atrial fibrillation are associated with increased mortality after transcatheter aortic valve replacement for aortic stenosis, whereas paroxysmal atrial fibrillation has no effect on mortality. These findings suggest that non-paroxysmal atrial fibrillation rather than paroxysmal atrial fibrillation may be associated with structural cardiac damage which is of prognostic significance in patients with aortic stenosis undergoing transcatheter aortic valve replacement.
Subject: 3126 Surgery, anesthesiology, intensive care, radiology
CLINICAL-OUTCOMES
INCREASED MORTALITY
IMPLANTATION
IMPACT
STENOSIS
MANAGEMENT
RISK
Referentgranskad: Ja
Licens: cc_by
Användningsbegränsning: openAccess
Parallelpublicerad version: publishedVersion


Filer under denna titel

Totalt antal nerladdningar: Laddar...

Filer Storlek Format Granska
journal.pone.0238953.pdf 508.3Kb PDF Granska/Öppna

Detta dokument registreras i samling:

Visa fullständig post